Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
מצבים רפואיים
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Queen Street,, Southport, Gold Coast, Australia
Contact: Principal Investigator (Jagadeesh Kurtkoti)Concord Repatriation General Hospital, Concord, New South Wales, Australia
Contact: Study coordinator (Helen Clayton) · SLHD-ConcordRenalResearch@health.nsw.gov.au · + 61 2 9767 6576Contact: Principal Investigator (Shaundeep Sen)Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinical Building, Burnside Drive, Liverpool, New South Wales, Australia
Contact: Principal Investigator (Angela Makris)Sydney Adventist Hospital, Wahroonga, New South Wales, Australia
Contact: Principal Investigator (Muhgeot Wong)Westmead Hospital, Clinical Research Unit, Level 6, B Wing/Building, Hawkesbury Road, Westmead, New South Wales, Australia
Contact: Principal Investigator (Gopala Rangan)Mater Hospital Brisbane, South Brisbane, Queensland, Australia
Contact: Principal Investigator (Michael Burke)St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
Contact: Principal Investigator (Veena Roberts, Dr)Sunshine Hospital, Western Centre for Health Research and Education, Level 3, 176-190 Furlong Road, Saint Albans, Victoria, Australia
Contact: Principal Investigator (Eugenia Pedagogos)Linear Clinical Research, Joondalup, Western Australia, Australia
Contact: Study coordinator (Brayden Ceravolo) · enquiries@linear.org.au; bceravolo@linear.org.au · 1300 546 327 / 08 6382 5110Contact: Principal Investigator (Dr Lara Hatchuel)Dr Hemant Kulkarni (Sub-investigator)Pacific Clinical Research Network Auckland, Takapuna, Auckland, New Zealand
Contact: Principal Investigator (Paul Hamilton, Dr)